QBI presents the inaugural QBI Bay Area Symposium on Chemical Biology on September 26–27, 2022, organized by Drs. Jim Wells, Kevan Shokat, Jason Gestwicki, Chris Chang, and Carolyn Bertozzi. Under the leadership of Dr.
Organized by Willow Coyote-Maestas, QBI presents the 2nd annual “Full Circle of Native and Indigenous Scientists in Quantitative Biology” symposium on November 17 and 18, 2022. The symposium will highlight Native and Indigenous scientists across the United States, and provide them with professional...
An illustration of neurons along with two types of damaging protein aggregates found in the Alzheimer’s disease brain: beta-amyloid plaques (brown) and tau protein tangles (blue). UCSF researchers have discovered a third type of aggregate associated with the disease, made of fragments of tau protein (not depicted).
Pharmaceutical chemist Arkin and neurologist Grinberg discover a new protein aggregate in Alzheimer’s disease.
The Quantitative Biosciences Institute (QBI) at UCSF is presenting a live Twitter interview hosted by QBI Fellow Kliment Verba to chat with his colleague Natalia Jura, who was the 27th recipient of the annual Byers Award in Basic Bi
Interim Dean Thomas E. Kearney, PharmD, places a graduation hood on Matthew Spencer Ocampo, PharmD ’22, during the UCSF School of Pharmacy’s 2022 Commencement.
Commencement ushers in a new normal for honoring the School’s graduates
The QBI & Gladstone Institute Infectious Disease and Human Health Seminar Series presents John Bridgeland, Founder & CEO of Civic, a social enterprise firm in Washington, D.C. He is also Executive Chairman of the Office of American Possibilities, a moonshot factory to tap the...
